| 品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| 阿拉丁 | C127596-5mg | 5mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C127596-25mg | 25mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C127596-100mg | 100mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C127596-1mg | 1mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C127596-10mg | 10mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C127596-50mg | 50mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, ≥97% |
|
|
| 阿拉丁 | C408435-1ml | 1ml | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
Moligand™, 10mM in DMSO |
|
|
| 罗恩 | R023973-5mg | 5mg | 5~7个工作日 | 1007207-67-1 |
[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢... 5-(7-methylsulfonyl-2-morpho... |
97% |
|
|
| 罗恩 | R023973-1mg | 1mg | 5~7个工作日 | 1007207-67-1 |
[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢... 5-(7-methylsulfonyl-2-morpho... |
97% |
|
|
| 罗恩 | R023973-25mg | 25mg | 5~7个工作日 | 1007207-67-1 |
[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢... 5-(7-methylsulfonyl-2-morpho... |
97% |
|
|
| 麦克林 | C873369-1mg | 1mg | 订前询问 | 1007207-67-1 |
CH5132799 CH5132799 |
0.98 |
|
|
| 麦克林 | C873369-25mg | 25mg | 订前询问 | 1007207-67-1 |
CH5132799 CH5132799 |
0.98 |
|
|
| 麦克林 | C873369-5mg | 5mg | 订前询问 | 1007207-67-1 |
CH5132799 CH5132799 |
0.98 |
|
|
| MARY | MR1341084-5mg | 5mg | 订前咨询 | 1007207-67-1 |
[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢... 5-(7-methylsulfonyl-2-morpho... |
97% |
|
|
| MARY | MR1341084-1mg | 1mg | 订前咨询 | 1007207-67-1 |
[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢... 5-(7-methylsulfonyl-2-morpho... |
97% |
|
|
| 源叶 | S80011-5mg | 5mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
≥97% |
|
|
| 源叶 | S80011-10mg | 10mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
≥97% |
|
|
| 源叶 | S80011-50mg | 50mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
≥97% |
|
|
| 源叶 | S80011-1mg | 1mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
≥97% |
|
|
| 源叶 | S80011-25mg | 25mg | 现货 | 1007207-67-1 |
CH5132799 CH5132799 |
≥97% |
|
|